DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 022185
» See Plans and Pricing
NDA 022185 describes TACLONEX, which is a drug marketed by Leo Pharma As and is included in two NDAs. There are two patents protecting this drug and one Paragraph IV challenge. Additional details are available on the TACLONEX profile page.
The generic ingredient in TACLONEX is betamethasone dipropionate; calcipotriene. There are sixty-six drug master file entries for this compound. Additional details are available on the betamethasone dipropionate; calcipotriene profile page.
The generic ingredient in TACLONEX is betamethasone dipropionate; calcipotriene. There are sixty-six drug master file entries for this compound. Additional details are available on the betamethasone dipropionate; calcipotriene profile page.
Summary for 022185
| Tradename: | TACLONEX |
| Applicant: | Leo Pharma As |
| Ingredient: | betamethasone dipropionate; calcipotriene |
| Patents: | 2 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;TOPICAL | Strength | 0.064%;0.005% | ||||
| Approval Date: | May 9, 2008 | TE: | AB | RLD: | Yes | ||||
| Regulatory Exclusivity Expiration: | Jan 25, 2023 | ||||||||
| Regulatory Exclusivity Use: | |||||||||
| Regulatory Exclusivity Expiration: | Jul 25, 2022 | ||||||||
| Regulatory Exclusivity Use: | |||||||||
| Patent: | Start Trial | Patent Expiration: | Jan 27, 2020 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Expired US Patents for NDA 022185
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Leo Pharma As | TACLONEX | betamethasone dipropionate; calcipotriene | SUSPENSION;TOPICAL | 022185-001 | May 9, 2008 | Start Trial | Start Trial |
| Leo Pharma As | TACLONEX | betamethasone dipropionate; calcipotriene | SUSPENSION;TOPICAL | 022185-001 | May 9, 2008 | Start Trial | Start Trial |
| Leo Pharma As | TACLONEX | betamethasone dipropionate; calcipotriene | SUSPENSION;TOPICAL | 022185-001 | May 9, 2008 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
